SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001078782-12-003242
Filing Date
2012-12-18
Accepted
2012-12-18 16:19:04
Documents
1
Period of Report
2012-12-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1424
  Complete submission text file 0001078782-12-003242.txt   2987
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25803 PEPPER BEND LANE KATY TX 77494
Business Address
Bassani August Shelby (Reporting) CIK: 0001564907 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52998 | Film No.: 121271560